专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2006045796A2 GASTRIC INHIBITORY POLYPEPTIDE (GIP) ANTIGEN ARRAYS AND USES THEREOF 审中-公开
标题翻译：胃肠抑制多肽（GIP）抗原阵列及其用途
公开(公告)号：WO2006045796A2
公开(公告)日：2006-05-04
申请号：PCT/EP2005/055529
申请日：2005-10-25
申请人： CYTOS BIOTECHNOLOGY AG , BACHMANN, Martin , FULURIJA, Alma , SAUDAN, Philippe
发明人： BACHMANN, Martin , FULURIJA, Alma , SAUDAN, Philippe
CPC分类号： C07K16/26 , A61K39/00 , A61K47/646 , A61K47/6901 , A61K2039/5258 , A61K2039/6075 , A61K2039/64 , C07K14/005 , C07K2317/34 , C12N7/00 , C12N2730/10122 , C12N2730/10123
摘要： The present invention is in the fields of medicine, public health, immunology, molecular biology and virology. The present invention provides, inter alia , a composition comprising a virus-like particle (VLP) and at least one antigen, wherein said antigen is a GIP protein or a GIP fragment linked to the VLP respectively. The invention also provides a method for producing the aforesaid composition. The compositions of this invention are useful in the production of vaccines, in particular, for the prevention and/or treatment of obesity and hereby, in particular, by inducing efficient immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context.
摘要翻译：本发明涉及医药，公共卫生，免疫学，分子生物学和病毒学领域。本发明尤其提供包含病毒样颗粒（VLP）和至少一种抗原的组合物，其中所述抗原是分别与VLP连接的GIP蛋白或GIP片段。本发明还提供了一种制备上述组合物的方法。本发明的组合物可用于疫苗的制备，特别是用于预防和/或治疗肥胖症，特别是通过诱导有效的免疫应答，特别是抗体应答。此外，本发明的组合物特别有用于在指定的上下文中有效诱导自身特异性免疫应答。

2. 发明申请

WO2006134125A1 ANTIGEN CONJUGATES AND USES THEREOF 审中-公开
标题翻译：抗原结合及其用途
公开(公告)号：WO2006134125A1
公开(公告)日：2006-12-21
申请号：PCT/EP2006/063198
申请日：2006-06-14
申请人： CYTOS BIOTECHNOLOGY AG , BACHMANN, Martin , TISSOT, Alain , JEGERLEHNER, Andrea , SAUDAN, Philippe , ZOU, Yu , SCHMITZ, Nicole , HUBER, Adrian , MARTIN, Stephen , HINTON, Heather
发明人： BACHMANN, Martin , TISSOT, Alain , JEGERLEHNER, Andrea , SAUDAN, Philippe , ZOU, Yu , SCHMITZ, Nicole , HUBER, Adrian , MARTIN, Stephen , HINTON, Heather
IPC分类号： A61K39/12 , C12N15/12 , C12N15/48 , C12N15/52
CPC分类号： A61K39/21 , A61K39/0005 , A61K39/0008 , A61K39/0011 , A61K39/12 , A61K47/646 , A61K2039/5258 , A61K2039/54 , A61K2039/545 , A61K2039/55505 , A61K2039/57 , A61K2039/6075 , A61K2039/622 , A61K2039/627 , A61K2039/64 , C07K2319/70 , C12N2740/16211 , C12N2740/16234 , C12N2795/18123
摘要： The present invention is in the fields of medicine, public health, immunology, molecular biology and virology. The invention provides composition comprising a virus-like particle (VLP) linked to at least one antigen of the invention, wherein said antigen of the invention is CCR5 of the invention, gastrin of the invention, CXCR4 of the invention, CETP of the invention or C5a of the invention. The invention also provides a process for producing the composition. The compositions of this invention are useful in the production of vaccines, in particular, for the treatment of diseases in which the antigen of the invention mediates, or contributes to the condition, particularly for the treatment of AIDS, gastrointestinal cancers, coronary heart diseases or inflammatory diseases. Moreover, the compositions of the invention induce efficient immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context.
摘要翻译：本发明涉及医药，公共卫生，免疫学，分子生物学和病毒学领域。本发明提供包含连接至本发明的至少一种抗原的病毒样颗粒（VLP）的组合物，其中本发明的所述抗原是本发明的CCR5，本发明的胃泌素，本发明的CXCR4，本发明的CETP或 C5a。本发明还提供了一种制备该组合物的方法。本发明的组合物可用于疫苗的生产，特别是用于治疗其中本发明的抗原介导或有助于该疾病的疾病，特别是用于治疗AIDS，胃肠癌，冠心病或炎性疾病。此外，本发明的组合物诱导有效的免疫应答，特别是抗体应答。此外，本发明的组合物特别有用于在指定的上下文中有效诱导自身特异性免疫应答。

3. 发明申请

WO2004096272A3 METHODS AND COMPOSITIONS FOR MODULATING THE INTERACTION BETWEEN ADIPONECTIN AND ITS RECEPTOR 审中-公开
公开(公告)号：WO2004096272A3
公开(公告)日：2004-11-11
申请号：PCT/EP2004/004473
申请日：2004-04-28
申请人： CYTOS BIOTECHNOLOGY AG , SAUDAN, Philippe , BACHMANN, Martin
发明人： SAUDAN, Philippe , BACHMANN, Martin
IPC分类号： G01N33/566
摘要： The invention is directed to methods for identifying agents that mimic or modulate the interaction between adiponectin and its receptor. In particular, the invention is directed to methods for mimicking or modulating the adiponectin-T-cadherin interaction in order to treat diseases and disorders associated with a deficiency or overabundance of adiponectin. Such diseases include, e.g., obesity, anorexia nervosa, type I and type II diabetes, coronary artery disease and atherosclerosis. The invention also provides isolated adiponectin-T-cadherin complexes and methods for identifying polypeptides that interact with adiponectin.

4. 发明申请

WO2010125202A1 INFLUENZA HEMAGGLUTININ COMPOSITIONS AND USES THEREOF 审中-公开
标题翻译：流感嗜血红蛋白组合物及其用途
公开(公告)号：WO2010125202A1
公开(公告)日：2010-11-04
申请号：PCT/EP2010/055944
申请日：2010-04-30
申请人： CYTOS BIOTECHNOLOGY AG , BACHMANN, Martin , JEGERLEHNER, Andrea , SAUDAN, Philippe
发明人： BACHMANN, Martin , JEGERLEHNER, Andrea , SAUDAN, Philippe
IPC分类号： A61K47/48 , A61P39/00
CPC分类号： A61K47/6901 , A61K47/646
摘要： The present invention is in the fields of medicine, public health, immunology, molecular biology and virology. The invention provides compositions, vaccine compositions and pharmaceutical compositions for the treatment, amelioration and / or prevention of influenza. The compositions, vaccine compositions and pharmaceutical compositions of the invention comprise a virus-like particle of an RNA bacteriophage and at least one antigen, wherein said at least one antigen is an ectodomain of an influenza virus hemagglutinin protein or a fragment of said ectodomain of an influenza virus hemagglutinin protein. When administered to an animal, preferably to a human, said compositions, vaccine compositions and pharmaceutical compositions efficiently induce immune responses, in particular antibody responses, wherein typically and preferably said antibody responses are directed against influenza virus. Thus, the invention further provides methods of treating, ameliorating and / or preventing influenza virus infection.
摘要翻译：本发明涉及医药，公共卫生，免疫学，分子生物学和病毒学领域。本发明提供用于治疗，改善和/或预防流感的组合物，疫苗组合物和药物组合物。本发明的组合物，疫苗组合物和药物组合物包含RNA噬菌体和至少一种抗原的病毒样颗粒，其中所述至少一种抗原是流感病毒血凝素蛋白的胞外域或所述胞外域的片段流感病毒血凝素蛋白。当施用于动物，优选给人时，所述组合物，疫苗组合物和药物组合物有效诱导免疫应答，特别是抗体应答，其中通常且优选地，所述抗体应答针对流感病毒。因此，本发明还提供了治疗，改善和/或预防流感病毒感染的方法。

5. 发明申请

WO2007039458A2 HIV PEPTIDE CONJUGATES AND USES THEREOF 审中-公开
标题翻译： HIV肽缀合物及其用途
公开(公告)号：WO2007039458A2
公开(公告)日：2007-04-12
申请号：PCT/EP2006/066526
申请日：2006-09-20
申请人： CYTOS BIOTECHNOLOGY AG , BACHMANN, Martin , SAUDAN, Philippe , JEGERLEHNER, Andrea , RÖHN, Till Alexander , JENNINGS, Gary
发明人： BACHMANN, Martin , SAUDAN, Philippe , JEGERLEHNER, Andrea , RÖHN, Till Alexander , JENNINGS, Gary
IPC分类号： A61K39/21 , C07K14/16
CPC分类号： C07K14/005 , A61K39/12 , A61K39/21 , A61K2039/5256 , A61K2039/5258 , C12N2740/16122 , C12N2740/16134 , C12N2795/18123
摘要： The present invention is in the fields of medicine, public health, immunology, molecular biology and virology. The invention provides composition comprising a virus-like particle (VLP) linked to at least one antigen, wherein said antigen is HIV gpl60 peptide. The invention also provides a process for producing the composition. The compositions of this invention are useful in the production of vaccines, in particular, for the prevention and treatment of diseases. Moreover, the compositions of the invention induce efficient immune responses, in particular antibody responses.
摘要翻译：本发明属于医学，公共卫生，免疫学，分子生物学和病毒学领域。本发明提供了包含与至少一种抗原连接的病毒样颗粒（VLP）的组合物，其中所述抗原是HIV gp160肽。本发明还提供了一种生产该组合物的方法。本发明的组合物可用于生产疫苗，特别是用于预防和治疗疾病。而且，本发明的组合物诱导有效的免疫应答，特别是抗体应答。

6. 发明申请

WO2006045849A1 T-CADHERIN ANTIGEN ARRAYS AND USES THEREOF 审中-公开
标题翻译： T-CADHERIN抗原阵列及其用途
公开(公告)号：WO2006045849A1
公开(公告)日：2006-05-04
申请号：PCT/EP2005/055668
申请日：2005-10-31
申请人： CYTOS BIOTECHNOLOGY AG , BACHMANN, Martin , SAUDAN, Philippe , TISSOT, Alain , DIETMEIER, Klaus
发明人： BACHMANN, Martin , SAUDAN, Philippe , TISSOT, Alain , DIETMEIER, Klaus
IPC分类号： A61K39/00 , A61K39/385 , C07K14/705 , C07K16/28
CPC分类号： A61K39/385 , A61K47/6901 , A61K2039/6075 , A61K2039/627
摘要： The present invention is in the fields of medicine, public health, immunology, molecular biology and virology. The present invention provides, inter alia, a composition comprising a virus-like particle (VLP) and at least one antigen, wherein said antigen is a T- cadherin domain protein, a combination of any T-cadherin domain proteins, a T-cadherin domain fragment or a combination of any T-cadherin domain fragments, linked to the VLP respectively. The invention also provides a method for producing the aforesaid composition. The compositions of this invention are useful in the production of vaccines, in particular, for the prevention and/or treatment of T-cadherin related disease, and hereby, in particular, by inducing efficient immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context.
摘要翻译：本发明涉及医药，公共卫生，免疫学，分子生物学和病毒学领域。本发明尤其提供包含病毒样颗粒（VLP）和至少一种抗原的组合物，其中所述抗原是T-钙粘蛋白结构域蛋白，任何T-cadherin结构域蛋白，T-钙粘蛋白结构域片段或与VLP分别连接的任何T-cadherin结构域片段的组合。本发明还提供了一种制备上述组合物的方法。本发明的组合物可用于疫苗的制备，特别是用于预防和/或治疗T-钙粘蛋白相关疾病，特别是通过诱导有效的免疫应答，特别是抗体应答。此外，本发明的组合物特别可用于在指定的上下文中有效诱导自身特异性免疫应答。

7. 发明申请

WO2006045796A3 GASTRIC INHIBITORY POLYPEPTIDE (GIP) ANTIGEN ARRAYS AND USES THEREOF 审中-公开
公开(公告)号：WO2006045796A3
公开(公告)日：2006-05-04
申请号：PCT/EP2005/055529
申请日：2005-10-25
申请人： CYTOS BIOTECHNOLOGY AG , BACHMANN, Martin , FULURIJA, Alma , SAUDAN, Philippe
发明人： BACHMANN, Martin , FULURIJA, Alma , SAUDAN, Philippe
IPC分类号： A61K47/48 , A61K38/26 , A61P3/10
摘要： The present invention is in the fields of medicine, public health, immunology, molecular biology and virology. The present invention provides, inter alia , a composition comprising a virus-like particle (VLP) and at least one antigen, wherein said antigen is a GIP protein or a GIP fragment linked to the VLP respectively. The invention also provides a method for producing the aforesaid composition. The compositions of this invention are useful in the production of vaccines, in particular, for the prevention and/or treatment of obesity and hereby, in particular, by inducing efficient immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context.

8. 发明申请

WO2009068335A1 HUMAN MONOCLONAL NICOTINE SPECIFIC ANTIBODIES 审中-公开
标题翻译：人类单克隆抗体特异性抗体
公开(公告)号：WO2009068335A1
公开(公告)日：2009-06-04
申请号：PCT/EP2008/062104
申请日：2008-09-11
申请人： CYTOS BIOTECHNOLOGY AG , BACHMANN, Martin , BAUER, Monika , BEERLI, Roger
发明人： BACHMANN, Martin , BAUER, Monika , BEERLI, Roger
IPC分类号： C07K16/16 , A61K39/395 , C07K16/44 , A61P25/34
CPC分类号： C07K16/16 , A61K2039/505 , C07K2317/21 , C07K2317/56 , C07K2317/565 , C07K2317/76 , C07K2317/92
摘要： The invention relates to recombinantly produced human monoclonalantibodies which are specifically binding nicotine and to nucleic acids encoding the same.The invention further relates to the use of such antibodies in the treatment of nicotine addiction.
摘要翻译：本发明涉及重组产生的特异性结合尼古丁的人单克隆抗体和编码该烟碱的核酸。本发明还涉及这种抗体在治疗尼古丁成瘾中的用途。

9. 发明申请

WO2008129020A1 VACCINATION REGIMEN FOR B-CELL VACCINES 审中-公开
标题翻译： B细胞疫苗的疫苗接种
公开(公告)号：WO2008129020A1
公开(公告)日：2008-10-30
申请号：PCT/EP2008/054775
申请日：2008-04-18
申请人： CYTOS BIOTECHNOLOGY AG , BACHMANN, Martin , MAURER, Patrik , MÜLLER, Philipp , PFISTER, Thomas , RENNER, Wolfgang
发明人： BACHMANN, Martin , MAURER, Patrik , MÜLLER, Philipp , PFISTER, Thomas , RENNER, Wolfgang
IPC分类号： A61K39/385 , A61K47/48 , A61P25/30
CPC分类号： A61K39/0013 , A61K47/646 , A61K47/6901 , A61K2039/5258 , A61K2039/55505
摘要： This invention relates to the field of vaccination and treatment or prevention diseases. In particular this invention relates to the treatment or prevention of diseases by inducing hapten-specific antibodyresponses in a vaccinated subject. The invention further provides a method forprevention or treatment of a disease by inducing hapten-specific antibodiesin asubject comprising administering into said subject acomposition comprising a virus-like particle of an RNA bacteriophage and at least one hapten linked thereto.
摘要翻译：本发明涉及疫苗接种和治疗或预防疾病领域。特别地，本发明涉及通过在接种疫苗的受试者中诱导半抗原特异性抗体应答来治疗或预防疾病。本发明进一步提供了一种预防或治疗疾病的方法，通过诱导半抗原特异性抗体作为对象，包括向所述受试者的复合物施用，其包含RNA噬菌体的病毒样颗粒和至少一种与其连接的半抗原。

10. 发明申请

WO2006097530A3 CAT ALLERGEN FUSION PROTEINS AND USES THEREOF 审中-公开
公开(公告)号：WO2006097530A3
公开(公告)日：2006-09-21
申请号：PCT/EP2006/060845
申请日：2006-03-17
申请人： CYTOS BIOTECHNOLOGY AG , BACHMANN, Martin , BAUER, Monika , DIETMEIER, Klaus , SCHMITZ, Nicole , UTZINGER, Stephan
发明人： BACHMANN, Martin , BAUER, Monika , DIETMEIER, Klaus , SCHMITZ, Nicole , UTZINGER, Stephan
IPC分类号： A61K39/35 , A61P37/08
摘要： The present invention is in the fields of medicine, public health, immunology, molecular biology and virology. The invention provides compositions comprising a virus-like particle (VLP) or a virus particle and at least one antigen, particularly at least one feline antigen, and more particularly at least one feline antigen that is a human allergen. In certain embodiments, the antigen is a Fel d1 antigen or a fragment thereof, covalently linked to the VLP. The invention also provides methods for producing the compositions. The compositions of the invention induce efficient immune responses, in particular antibody responses, in mammals, particularly humans. The compositions and methods of the invention are useful in the production of vaccines, in particular for the treatment and/or prevention of allergies to cat dander and other cat antigens and allergens.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式